+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Gut Microbiota Market - Global Forecast 2026-2032

  • Report

  • 192 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6090143
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Gut Microbiota Market is projected to reach USD 1.03 Billion in 2026. It is expected to continue growing at a CAGR of 10.38%, reaching USD 1.88 Billion by 2032.

Gut Microbiota: Executive Summary

Gut microbiota research examines the diverse microorganisms living in the digestive tract and their interactions with nutrition, immunity, metabolism, and the nervous system. Evidence indicates that microbial composition and function vary with diet, age, medication exposure, geography, and health status. The field spans basic science, diagnostics, nutrition, therapeutics, and preventive health, while clinical translation remains dependent on stronger validation and standardized measurement.

Transformative Shifts Reshaping Gut Microbiota Research

The landscape is shifting from cataloguing microbial species toward understanding microbial functions, metabolites, host interactions, and causal mechanisms. Advances in sequencing, metabolomics, culturing, computational biology, and longitudinal study design are improving resolution, but differences in sample collection, analysis pipelines, and reporting continue to limit comparability. Interest is also moving toward precision nutrition, live biotherapeutic products, postbiotics, dietary fibre, and microbiota-informed clinical care, alongside greater scrutiny of safety, reproducibility, and regulatory evidence.

How Artificial Intelligence Is Advancing Microbiota Analysis

Artificial intelligence is being applied to classify microbial communities, identify disease-associated patterns, integrate sequencing with clinical and metabolomic data, and generate hypotheses about host-microbe interactions. Machine-learning models may support patient stratification and treatment-response assessment, but their reliability depends on representative datasets, consistent laboratory methods, external validation, and transparent interpretation. Privacy, bias, biological confounding, and the risk of mistaking association for causation remain important constraints.

Regional Insights Across the Gut Microbiota Landscape

North America has strong activity in translational research, clinical studies, biotechnology, and regulatory discussion. Europe emphasizes multicentre research, food and health policy, and data governance, while Asia-Pacific reflects substantial dietary diversity, expanding biomedical capacity, and growing interest in microbiome-enabled nutrition and therapeutics. Latin America contributes valuable population and dietary diversity but faces uneven research infrastructure. The Middle East is developing clinical and academic capabilities, with diet, metabolic health, and local population studies receiving attention. Africa offers important opportunities to study underrepresented microbiota profiles and environmental influences, although laboratory access, funding continuity, and data infrastructure remain uneven.

Group-Level Patterns Across ASEAN, BRICS, EU, G7, GCC, and NATO

ASEAN countries provide diverse dietary, environmental, and population settings, supporting comparative microbiota research while requiring stronger harmonization. BRICS members bring large and varied populations, expanding research capacity, and substantial differences in healthcare infrastructure, but collaboration is affected by data-access and methodological variation. The European Union benefits from coordinated research frameworks and shared regulatory structures. G7 countries generally combine advanced sequencing, clinical research, and computational resources. GCC states are increasingly focused on metabolic health and region-specific cohorts, while NATO members offer extensive scientific networks and health-security infrastructure, although these groupings are not uniform research or regulatory markets.

Country-Level Signals in Gut Microbiota Research

Australia supports research linking microbiota with nutrition, immune health, and indigenous population diversity. Brazil and Mexico offer important Latin American cohorts shaped by dietary and socioeconomic variation. Canada and the United States maintain broad capabilities in clinical, computational, and translational research. China and India contribute large, diverse populations and expanding microbiology and sequencing capacity. Japan and South Korea are active in nutrition, aging, gastrointestinal health, and precision medicine research. France, Germany, Italy, and Spain combine strong academic and clinical systems with European data and regulatory frameworks. The United Kingdom has substantial expertise in population studies, clinical translation, and bioinformatics. Russia contributes scientific capacity, although collaboration and data-access conditions may vary across institutions.

Priorities for Industry Leaders Building Credible Microbiota Solutions

Leaders should prioritize well-characterized cohorts, standardized sample handling, validated analytical workflows, and prospective clinical evidence rather than relying on correlations alone. Product and service development should define measurable biological and clinical endpoints, address safety and contamination risks, and establish clear claims supported by appropriate evidence. Partnerships spanning nutrition, gastroenterology, immunology, data science, and public health can improve translation. Organizations should also invest in interoperable data systems, explainable models, diverse recruitment, transparent reporting, and regulatory engagement from the earliest development stages.

Research Methodology for the Executive Summary

This summary uses a structured synthesis of established findings in gut microbiota science, including peer-reviewed research themes, clinical translation considerations, technological developments, and geographic research patterns. Insights are organized across biological mechanisms, enabling technologies, applications, regional systems, economic groupings, and country contexts. Because the supplied reference identifies the topic but provides no underlying dataset, the summary avoids numerical market claims and presents qualitative, evidence-aligned interpretation rather than estimates or forecasts.

Conclusion: From Microbial Profiles to Validated Clinical Utility

Gut microbiota research is progressing toward functionally informed, patient-specific applications, supported by improvements in sequencing, multi-omics, culturing, and artificial intelligence. The central challenge is converting complex associations into reproducible mechanisms and clinically meaningful outcomes. Progress will depend on standardized methods, diverse and longitudinal cohorts, rigorous validation, responsible data practices, and collaboration across disciplines and regions. Organizations that combine scientific credibility with careful translation are best positioned to contribute durable value to the field.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Gut Microbiota Market, by Product Type
7.1. Introduction
7.2. Microbiome Testing Services
7.3. Postbiotics
7.4. Prebiotics
7.5. Probiotics
7.6. Synbiotics
8. Gut Microbiota Market, by Form
8.1. Introduction
8.2. Capsules
8.3. Liquid
8.4. Powder
8.5. Tablet
9. Gut Microbiota Market, by Application
9.1. Introduction
9.2. Animal Feed
9.3. Dietary Supplements
9.4. Functional Food & Beverages
9.5. Personal Care
9.6. Pharmaceuticals
10. Gut Microbiota Market, by Indication
10.1. Introduction
10.2. Allergies
10.3. Autoimmune Disorder
10.4. Diabetes
10.5. Inflammatory Bowel Disease
10.6. Irritable Bowel Syndrome
10.7. Obesity
11. Gut Microbiota Market, by End User
11.1. Introduction
11.2. Home Use
11.3. Hospitals & Clinics
11.4. Research Institutes
12. Gut Microbiota Market, by Distribution Channel
12.1. Introduction
12.2. Hospital Pharmacy
12.3. Online Pharmacy
12.4. Retail Pharmacy
13. Gut Microbiota Market, by Region
13.1. Introduction
13.2. Asia-Pacific
13.3. North America
13.4. Latin America
13.5. Europe
13.6. Middle East
13.7. Africa
14. Gut Microbiota Market, by Group
14.1. Introduction
14.2. ASEAN
14.3. GCC
14.4. European Union
14.5. BRICS
14.6. G7
14.7. NATO
15. Gut Microbiota Market, by Country
15.1. Introduction
15.2. United States
15.3. Germany
15.4. China
15.5. United Kingdom
15.6. India
15.7. Japan
15.8. Russia
15.9. Brazil
15.10. Canada
15.11. Italy
15.12. Mexico
15.13. France
15.14. Spain
15.15. Australia
15.16. South Korea
16. Competitive Landscape
16.1. Market Share Analysis, 2025
16.2. Market Concentration Analysis, 2025
16.2.1. Concentration Ratio (CR)
16.2.2. Herfindahl Hirschman Index (HHI)
16.3. Recent Developments & Impact Analysis, 2025
16.4. Product Portfolio Analysis, 2025
16.5. Benchmarking Analysis, 2025
17. Company Profiles
17.1. Abbott Laboratories
17.2. Archer-Daniels-Midland Company
17.3. Astellas Pharma Inc.
17.4. Axial Therapeutics, Inc.
17.5. Biocodex S.A.
17.6. BioGaia USA
17.7. BiomX Inc.
17.8. Danone S.A.
17.9. Enterome
17.10. Finch Therapeutics Group, Inc
17.11. International Flavors & Fragrances Inc.
17.12. Johnson & Johnson Services, Inc.
17.13. Kerry Group plc
17.14. Lallemand Inc.
17.15. Lesaffre International, SAS
17.16. Meiji Holdings Co., Ltd.
17.17. Morinaga Milk Industry Co., Ltd.
17.18. Nestlé S.A
17.19. Novonesis Group
17.20. Pfizer Inc.
17.21. Probi AB
17.22. Royal FrieslandCampina NV
17.23. Seed Health, Inc
17.24. Seres Therapeutics, Inc.
17.25. Sun Genomics, Inc.
17.26. Synlogic, Inc.
17.27. Vedanta Biosciences, Inc.
17.28. Viome Life Sciences, Inc
17.29. Yakult Honsha Co., Ltd.
18. Key Experts
LIST OF FIGURES
FIGURE 1. Global Gut Microbiota Market, Years Considered for the Study
FIGURE 2. Global Gut Microbiota Market, Research Design
FIGURE 3. Global Gut Microbiota Market, Research Framework
FIGURE 4. Global Gut Microbiota Market, Data Triangulation
FIGURE 5. Global Gut Microbiota Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Gut Microbiota Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 7. Global Gut Microbiota Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Gut Microbiota Market Size, by Form, 2025 vs 2032 (%)
FIGURE 9. Global Gut Microbiota Market Size, by Form, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Gut Microbiota Market Size, by Application, 2025 vs 2032 (%)
FIGURE 11. Global Gut Microbiota Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Gut Microbiota Market Size, by Indication, 2025 vs 2032 (%)
FIGURE 13. Global Gut Microbiota Market Size, by Indication, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Gut Microbiota Market Size, by End User, 2025 vs 2032 (%)
FIGURE 15. Global Gut Microbiota Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Gut Microbiota Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 17. Global Gut Microbiota Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Gut Microbiota Market Size, by Region, 2025 vs 2032 (%)
FIGURE 19. Global Gut Microbiota Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 20. Global Gut Microbiota Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Gut Microbiota Market Size, by Country, 2025 vs 2032 (%)
FIGURE 22. Global Gut Microbiota Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 23. Global Gut Microbiota Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Gut Microbiota Market Segmentation & Coverage
TABLE 2. Global Gut Microbiota Market Size, 2017-2032 (USD Million)
TABLE 3. Global Gut Microbiota Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 4. Global Microbiome Testing Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Microbiome Testing Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Microbiome Testing Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Postbiotics Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Postbiotics Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Postbiotics Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Prebiotics Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Prebiotics Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Prebiotics Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Probiotics Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Probiotics Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Probiotics Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Synbiotics Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Synbiotics Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Synbiotics Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Gut Microbiota Market Size, by Form, 2017-2032 (USD Million)
TABLE 20. Global Capsules Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Capsules Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Capsules Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Liquid Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Liquid Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Liquid Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Powder Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global Powder Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global Powder Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global Tablet Market Size, by Region, 2017-2032 (USD Million)
TABLE 30. Global Tablet Market Size, by Group, 2017-2032 (USD Million)
TABLE 31. Global Tablet Market Size, by Country, 2017-2032 (USD Million)
TABLE 32. Global Gut Microbiota Market Size, by Application, 2017-2032 (USD Million)
TABLE 33. Global Animal Feed Market Size, by Region, 2017-2032 (USD Million)
TABLE 34. Global Animal Feed Market Size, by Group, 2017-2032 (USD Million)
TABLE 35. Global Animal Feed Market Size, by Country, 2017-2032 (USD Million)
TABLE 36. Global Dietary Supplements Market Size, by Region, 2017-2032 (USD Million)
TABLE 37. Global Dietary Supplements Market Size, by Group, 2017-2032 (USD Million)
TABLE 38. Global Dietary Supplements Market Size, by Country, 2017-2032 (USD Million)
TABLE 39. Global Functional Food & Beverages Market Size, by Region, 2017-2032 (USD Million)
TABLE 40. Global Functional Food & Beverages Market Size, by Group, 2017-2032 (USD Million)
TABLE 41. Global Functional Food & Beverages Market Size, by Country, 2017-2032 (USD Million)
TABLE 42. Global Personal Care Market Size, by Region, 2017-2032 (USD Million)
TABLE 43. Global Personal Care Market Size, by Group, 2017-2032 (USD Million)
TABLE 44. Global Personal Care Market Size, by Country, 2017-2032 (USD Million)
TABLE 45. Global Pharmaceuticals Market Size, by Region, 2017-2032 (USD Million)
TABLE 46. Global Pharmaceuticals Market Size, by Group, 2017-2032 (USD Million)
TABLE 47. Global Pharmaceuticals Market Size, by Country, 2017-2032 (USD Million)
TABLE 48. Global Gut Microbiota Market Size, by Indication, 2017-2032 (USD Million)
TABLE 49. Global Allergies Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Global Allergies Market Size, by Group, 2017-2032 (USD Million)
TABLE 51. Global Allergies Market Size, by Country, 2017-2032 (USD Million)
TABLE 52. Global Autoimmune Disorder Market Size, by Region, 2017-2032 (USD Million)
TABLE 53. Global Autoimmune Disorder Market Size, by Group, 2017-2032 (USD Million)
TABLE 54. Global Autoimmune Disorder Market Size, by Country, 2017-2032 (USD Million)
TABLE 55. Global Diabetes Market Size, by Region, 2017-2032 (USD Million)
TABLE 56. Global Diabetes Market Size, by Group, 2017-2032 (USD Million)
TABLE 57. Global Diabetes Market Size, by Country, 2017-2032 (USD Million)
TABLE 58. Global Inflammatory Bowel Disease Market Size, by Region, 2017-2032 (USD Million)
TABLE 59. Global Inflammatory Bowel Disease Market Size, by Group, 2017-2032 (USD Million)
TABLE 60. Global Inflammatory Bowel Disease Market Size, by Country, 2017-2032 (USD Million)
TABLE 61. Global Irritable Bowel Syndrome Market Size, by Region, 2017-2032 (USD Million)
TABLE 62. Global Irritable Bowel Syndrome Market Size, by Group, 2017-2032 (USD Million)
TABLE 63. Global Irritable Bowel Syndrome Market Size, by Country, 2017-2032 (USD Million)
TABLE 64. Global Obesity Market Size, by Region, 2017-2032 (USD Million)
TABLE 65. Global Obesity Market Size, by Group, 2017-2032 (USD Million)
TABLE 66. Global Obesity Market Size, by Country, 2017-2032 (USD Million)
TABLE 67. Global Gut Microbiota Market Size, by End User, 2017-2032 (USD Million)
TABLE 68. Global Home Use Market Size, by Region, 2017-2032 (USD Million)
TABLE 69. Global Home Use Market Size, by Group, 2017-2032 (USD Million)
TABLE 70. Global Home Use Market Size, by Country, 2017-2032 (USD Million)
TABLE 71. Global Hospitals & Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 72. Global Hospitals & Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 73. Global Hospitals & Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 74. Global Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 75. Global Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 76. Global Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 77. Global Gut Microbiota Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 78. Global Hospital Pharmacy Market Size, by Region, 2017-2032 (USD Million)
TABLE 79. Global Hospital Pharmacy Market Size, by Group, 2017-2032 (USD Million)
TABLE 80. Global Hospital Pharmacy Market Size, by Country, 2017-2032 (USD Million)
TABLE 81. Global Online Pharmacy Market Size, by Region, 2017-2032 (USD Million)
TABLE 82. Global Online Pharmacy Market Size, by Group, 2017-2032 (USD Million)
TABLE 83. Global Online Pharmacy Market Size, by Country, 2017-2032 (USD Million)
TABLE 84. Global Retail Pharmacy Market Size, by Region, 2017-2032 (USD Million)
TABLE 85. Global Retail Pharmacy Market Size, by Group, 2017-2032 (USD Million)
TABLE 86. Global Retail Pharmacy Market Size, by Country, 2017-2032 (USD Million)
TABLE 87. Global Gut Microbiota Market Size, by Region, 2017-2032 (USD Million)
TABLE 88. Asia-Pacific Gut Microbiota Market Size, by Region, 2017-2032 (USD Million)
TABLE 89. Asia-Pacific Gut Microbiota Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 90. Asia-Pacific Gut Microbiota Market Size, by Form, 2017-2032 (USD Million)
TABLE 91. Asia-Pacific Gut Microbiota Market Size, by Application, 2017-2032 (USD Million)
TABLE 92. Asia-Pacific Gut Microbiota Market Size, by Indication, 2017-2032 (USD Million)
TABLE 93. Asia-Pacific Gut Microbiota Market Size, by End User, 2017-2032 (USD Million)
TABLE 94. Asia-Pacific Gut Microbiota Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 95. North America Gut Microbiota Market Size, by Region, 2017-2032 (USD Million)
TABLE 96. North America Gut Microbiota Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 97. North America Gut Microbiota Market Size, by Form, 2017-2032 (USD Million)
TABLE 98. North America Gut Microbiota Market Size, by Application, 2017-2032 (USD Million)
TABLE 99. North America Gut Microbiota Market Size, by Indication, 2017-2032 (USD Million)
TABLE 100. North America Gut Microbiota Market Size, by End User, 2017-2032 (USD Million)
TABLE 101. North America Gut Microbiota Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 102. Latin America Gut Microbiota Market Size, by Region, 2017-2032 (USD Million)
TABLE 103. Latin America Gut Microbiota Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 104. Latin America Gut Microbiota Market Size, by Form, 2017-2032 (USD Million)
TABLE 105. Latin America Gut Microbiota Market Size, by Application, 2017-2032 (USD Million)
TABLE 106. Latin America Gut Microbiota Market Size, by Indication, 2017-2032 (USD Million)
TABLE 107. Latin America Gut Microbiota Market Size, by End User, 2017-2032 (USD Million)
TABLE 108. Latin America Gut Microbiota Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 109. Europe Gut Microbiota Market Size, by Region, 2017-2032 (USD Million)
TABLE 110. Europe Gut Microbiota Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 111. Europe Gut Microbiota Market Size, by Form, 2017-2032 (USD Million)
TABLE 112. Europe Gut Microbiota Market Size, by Application, 2017-2032 (USD Million)
TABLE 113. Europe Gut Microbiota Market Size, by Indication, 2017-2032 (USD Million)
TABLE 114. Europe Gut Microbiota Market Size, by End User, 2017-2032 (USD Million)
TABLE 115. Europe Gut Microbiota Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 116. Middle East Gut Microbiota Market Size, by Region, 2017-2032 (USD Million)
TABLE 117. Middle East Gut Microbiota Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 118. Middle East Gut Microbiota Market Size, by Form, 2017-2032 (USD Million)
TABLE 119. Middle East Gut Microbiota Market Size, by Application, 2017-2032 (USD Million)
TABLE 120. Middle East Gut Microbiota Market Size, by Indication, 2017-2032 (USD Million)
TABLE 121. Middle East Gut Microbiota Market Size, by End User, 2017-2032 (USD Million)
TABLE 122. Middle East Gut Microbiota Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 123. Africa Gut Microbiota Market Size, by Region, 2017-2032 (USD Million)
TABLE 124. Africa Gut Microbiota Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 125. Africa Gut Microbiota Market Size, by Form, 2017-2032 (USD Million)
TABLE 126. Africa Gut Microbiota Market Size, by Application, 2017-2032 (USD Million)
TABLE 127. Africa Gut Microbiota Market Size, by Indication, 2017-2032 (USD Million)
TABLE 128. Africa Gut Microbiota Market Size, by End User, 2017-2032 (USD Million)
TABLE 129. Africa Gut Microbiota Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 130. Global Gut Microbiota Market Size, by Group, 2017-2032 (USD Million)
TABLE 131. ASEAN Gut Microbiota Market Size, by Group, 2017-2032 (USD Million)
TABLE 132. ASEAN Gut Microbiota Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 133. ASEAN Gut Microbiota Market Size, by Form, 2017-2032 (USD Million)
TABLE 134. ASEAN Gut Microbiota Market Size, by Application, 2017-2032 (USD Million)
TABLE 135. ASEAN Gut Microbiota Market Size, by Indication, 2017-2032 (USD Million)
TABLE 136. ASEAN Gut Microbiota Market Size, by End User, 2017-2032 (USD Million)
TABLE 137. ASEAN Gut Microbiota Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 138. GCC Gut Microbiota Market Size, by Group, 2017-2032 (USD Million)
TABLE 139. GCC Gut Microbiota Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 140. GCC Gut Microbiota Market Size, by Form, 2017-2032 (USD Million)
TABLE 141. GCC Gut Microbiota Market Size, by Application, 2017-2032 (USD Million)
TABLE 142. GCC Gut Microbiota Market Size, by Indication, 2017-2032 (USD Million)
TABLE 143. GCC Gut Microbiota Market Size, by End User, 2017-2032 (USD Million)
TABLE 144. GCC Gut Microbiota Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 145. European Union Gut Microbiota Market Size, by Group, 2017-2032 (USD Million)
TABLE 146. European Union Gut Microbiota Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 147. European Union Gut Microbiota Market Size, by Form, 2017-2032 (USD Million)
TABLE 148. European Union Gut Microbiota Market Size, by Application, 2017-2032 (USD Million)
TABLE 149. European Union Gut Microbiota Market Size, by Indication, 2017-2032 (USD Million)
TABLE 150. European Union Gut Microbiota Market Size, by End User, 2017-2032 (USD Million)
TABLE 151. European Union Gut Microbiota Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 152. BRICS Gut Microbiota Market Size, by Group, 2017-2032 (USD Million)
TABLE 153. BRICS Gut Microbiota Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 154. BRICS Gut Microbiota Market Size, by Form, 2017-2032 (USD Million)
TABLE 155. BRICS Gut Microbiota Market Size, by Application, 2017-2032 (USD Million)
TABLE 156. BRICS Gut Microbiota Market Size, by Indication, 2017-2032 (USD Million)
TABLE 157. BRICS Gut Microbiota Market Size, by End User, 2017-2032 (USD Million)
TABLE 158. BRICS Gut Microbiota Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 159. G7 Gut Microbiota Market Size, by Group, 2017-2032 (USD Million)
TABLE 160. G7 Gut Microbiota Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 161. G7 Gut Microbiota Market Size, by Form, 2017-2032 (USD Million)
TABLE 162. G7 Gut Microbiota Market Size, by Application, 2017-2032 (USD Million)
TABLE 163. G7 Gut Microbiota Market Size, by Indication, 2017-2032 (USD Million)
TABLE 164. G7 Gut Microbiota Market Size, by End User, 2017-2032 (USD Million)
TABLE 165. G7 Gut Microbiota Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 166. NATO Gut Microbiota Market Size, by Group, 2017-2032 (USD Million)
TABLE 167. NATO Gut Microbiota Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 168. NATO Gut Microbiota Market Size, by Form, 2017-2032 (USD Million)
TABLE 169. NATO Gut Microbiota Market Size, by Application, 2017-2032 (USD Million)
TABLE 170. NATO Gut Microbiota Market Size, by Indication, 2017-2032 (USD Million)
TABLE 171. NATO Gut Microbiota Market Size, by End User, 2017-2032 (USD Million)
TABLE 172. NATO Gut Microbiota Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 173. Global Gut Microbiota Market Size, by Country, 2017-2032 (USD Million)
TABLE 174. United States Gut Microbiota Market Size, 2017-2032 (USD Million)
TABLE 175. United States Gut Microbiota Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 176. United States Gut Microbiota Market Size, by Form, 2017-2032 (USD Million)
TABLE 177. United States Gut Microbiota Market Size, by Application, 2017-2032 (USD Million)
TABLE 178. United States Gut Microbiota Market Size, by Indication, 2017-2032 (USD Million)
TABLE 179. United States Gut Microbiota Market Size, by End User, 2017-2032 (USD Million)
TABLE 180. United States Gut Microbiota Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 181. Germany Gut Microbiota Market Size, 2017-2032 (USD Million)
TABLE 182. Germany Gut Microbiota Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 183. Germany Gut Microbiota Market Size, by Form, 2017-2032 (USD Million)
TABLE 184. Germany Gut Microbiota Market Size, by Application, 2017-2032 (USD Million)
TABLE 185. Germany Gut Microbiota Market Size, by Indication, 2017-2032 (USD Million)
TABLE 186. Germany Gut Microbiota Market Size, by End User, 2017-2032 (USD Million)
TABLE 187. Germany Gut Microbiota Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 188. China Gut Microbiota Market Size, 2017-2032 (USD Million)
TABLE 189. China Gut Microbiota Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 190. China Gut Microbiota Market Size, by Form, 2017-2032 (USD Million)
TABLE 191. China Gut Microbiota Market Size, by Application, 2017-2032 (USD Million)
TABLE 192. China Gut Microbiota Market Size, by Indication, 2017-2032 (USD Million)
TABLE 193. China Gut Microbiota Market Size, by End User, 2017-2032 (USD Million)
TABLE 194. China Gut Microbiota Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 195. United Kingdom Gut Microbiota Market Size, 2017-2032 (USD Million)
TABLE 196. United Kingdom Gut Microbiota Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 197. United Kingdom Gut Microbiota Market Size, by Form, 2017-2032 (USD Million)
TABLE 198. United Kingdom Gut Microbiota Market Size, by Application, 2017-2032 (USD Million)
TABLE 199. United Kingdom Gut Microbiota Market Size, by Indication, 2017-2032 (USD Million)
TABLE 200. United Kingdom Gut Microbiota Market Size, by End User, 2017-2032 (USD Million)
TABLE 201. United Kingdom Gut Microbiota Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 202. India Gut Microbiota Market Size, 2017-2032 (USD Million)
TABLE 203. India Gut Microbiota Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 204. India Gut Microbiota Market Size, by Form, 2017-2032 (USD Million)
TABLE 205. India Gut Microbiota Market Size, by Application, 2017-2032 (USD Million)
TABLE 206. India Gut Microbiota Market Size, by Indication, 2017-2032 (USD Million)
TABLE 207. India Gut Microbiota Market Size, by End User, 2017-2032 (USD Million)
TABLE 208. India Gut Microbiota Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 209. Japan Gut Microbiota Market Size, 2017-2032 (USD Million)
TABLE 210. Japan Gut Microbiota Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 211. Japan Gut Microbiota Market Size, by Form, 2017-2032 (USD Million)
TABLE 212. Japan Gut Microbiota Market Size, by Application, 2017-2032 (USD Million)
TABLE 213. Japan Gut Microbiota Market Size, by Indication, 2017-2032 (USD Million)
TABLE 214. Japan Gut Microbiota Market Size, by End User, 2017-2032 (USD Million)
TABLE 215. Japan Gut Microbiota Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 216. Russia Gut Microbiota Market Size, 2017-2032 (USD Million)
TABLE 217. Russia Gut Microbiota Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 218. Russia Gut Microbiota Market Size, by Form, 2017-2032 (USD Million)
TABLE 219. Russia Gut Microbiota Market Size, by Application, 2017-2032 (USD Million)
TABLE 220. Russia Gut Microbiota Market Size, by Indication, 2017-2032 (USD Million)
TABLE 221. Russia Gut Microbiota Market Size, by End User, 2017-2032 (USD Million)
TABLE 222. Russia Gut Microbiota Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 223. Brazil Gut Microbiota Market Size, 2017-2032 (USD Million)
TABLE 224. Brazil Gut Microbiota Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 225. Brazil Gut Microbiota Market Size, by Form, 2017-2032 (USD Million)
TABLE 226. Brazil Gut Microbiota Market Size, by Application, 2017-2032 (USD Million)
TABLE 227. Brazil Gut Microbiota Market Size, by Indication, 2017-2032 (USD Million)
TABLE 228. Brazil Gut Microbiota Market Size, by End User, 2017-2032 (USD Million)
TABLE 229. Brazil Gut Microbiota Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 230. Canada Gut Microbiota Market Size, 2017-2032 (USD Million)
TABLE 231. Canada Gut Microbiota Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 232. Canada Gut Microbiota Market Size, by Form, 2017-2032 (USD Million)
TABLE 233. Canada Gut Microbiota Market Size, by Application, 2017-2032 (USD Million)
TABLE 234. Canada Gut Microbiota Market Size, by Indication, 2017-2032 (USD Million)
TABLE 235. Canada Gut Microbiota Market Size, by End User, 2017-2032 (USD Million)
TABLE 236. Canada Gut Microbiota Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 237. Italy Gut Microbiota Market Size, 2017-2032 (USD Million)
TABLE 238. Italy Gut Microbiota Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 239. Italy Gut Microbiota Market Size, by Form, 2017-2032 (USD Million)
TABLE 240. Italy Gut Microbiota Market Size, by Application, 2017-2032 (USD Million)
TABLE 241. Italy Gut Microbiota Market Size, by Indication, 2017-2032 (USD Million)
TABLE 242. Italy Gut Microbiota Market Size, by End User, 2017-2032 (USD Million)
TABLE 243. Italy Gut Microbiota Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 244. Mexico Gut Microbiota Market Size, 2017-2032 (USD Million)
TABLE 245. Mexico Gut Microbiota Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 246. Mexico Gut Microbiota Market Size, by Form, 2017-2032 (USD Million)
TABLE 247. Mexico Gut Microbiota Market Size, by Application, 2017-2032 (USD Million)
TABLE 248. Mexico Gut Microbiota Market Size, by Indication, 2017-2032 (USD Million)
TABLE 249. Mexico Gut Microbiota Market Size, by End User, 2017-2032 (USD Million)
TABLE 250. Mexico Gut Microbiota Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 251. France Gut Microbiota Market Size, 2017-2032 (USD Million)
TABLE 252. France Gut Microbiota Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 253. France Gut Microbiota Market Size, by Form, 2017-2032 (USD Million)
TABLE 254. France Gut Microbiota Market Size, by Application, 2017-2032 (USD Million)
TABLE 255. France Gut Microbiota Market Size, by Indication, 2017-2032 (USD Million)
TABLE 256. France Gut Microbiota Market Size, by End User, 2017-2032 (USD Million)
TABLE 257. France Gut Microbiota Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 258. Spain Gut Microbiota Market Size, 2017-2032 (USD Million)
TABLE 259. Spain Gut Microbiota Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 260. Spain Gut Microbiota Market Size, by Form, 2017-2032 (USD Million)
TABLE 261. Spain Gut Microbiota Market Size, by Application, 2017-2032 (USD Million)
TABLE 262. Spain Gut Microbiota Market Size, by Indication, 2017-2032 (USD Million)
TABLE 263. Spain Gut Microbiota Market Size, by End User, 2017-2032 (USD Million)
TABLE 264. Spain Gut Microbiota Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 265. Australia Gut Microbiota Market Size, 2017-2032 (USD Million)
TABLE 266. Australia Gut Microbiota Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 267. Australia Gut Microbiota Market Size, by Form, 2017-2032 (USD Million)
TABLE 268. Australia Gut Microbiota Market Size, by Application, 2017-2032 (USD Million)
TABLE 269. Australia Gut Microbiota Market Size, by Indication, 2017-2032 (USD Million)
TABLE 270. Australia Gut Microbiota Market Size, by End User, 2017-2032 (USD Million)
TABLE 271. Australia Gut Microbiota Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 272. South Korea Gut Microbiota Market Size, 2017-2032 (USD Million)
TABLE 273. South Korea Gut Microbiota Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 274. South Korea Gut Microbiota Market Size, by Form, 2017-2032 (USD Million)
TABLE 275. South Korea Gut Microbiota Market Size, by Application, 2017-2032 (USD Million)
TABLE 276. South Korea Gut Microbiota Market Size, by Indication, 2017-2032 (USD Million)
TABLE 277. South Korea Gut Microbiota Market Size, by End User, 2017-2032 (USD Million)
TABLE 278. South Korea Gut Microbiota Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 279. Global Gut Microbiota Market Share, by Key Player, 2025
TABLE 280. Global Gut Microbiota Market, Key Experts

Companies Mentioned

  • Abbott Laboratories
  • Archer-Daniels-Midland Company
  • Astellas Pharma Inc.
  • Axial Therapeutics, Inc.
  • Biocodex S.A.
  • BioGaia USA
  • BiomX Inc.
  • Danone S.A.
  • Enterome
  • Finch Therapeutics Group, Inc
  • International Flavors & Fragrances Inc.
  • Johnson & Johnson Services, Inc.
  • Kerry Group plc
  • Lallemand Inc.
  • Lesaffre International, SAS
  • Meiji Holdings Co., Ltd.
  • Morinaga Milk Industry Co., Ltd.
  • Nestlé S.A
  • Novonesis Group
  • Pfizer Inc.
  • Probi AB
  • Royal FrieslandCampina NV
  • Seed Health, Inc
  • Seres Therapeutics, Inc.
  • Sun Genomics, Inc.
  • Synlogic, Inc.
  • Vedanta Biosciences, Inc.
  • Viome Life Sciences, Inc
  • Yakult Honsha Co., Ltd.